You are here

gout

BioCryst jumps ahead of study presentation

Marketwatch

Wed, 06/6/12 - 03:33 pm

Regeneron: FDA panel says no to Arcalyst for gout

Yahoo/AP

Tue, 05/8/12 - 07:19 pm

Myth Versus Reality: Promoting A Pricey Gout Pill

Pharmalot

Fri, 01/6/12 - 01:36 pm

Savient's Krystexxa: How I Get A $209 Million Sales Estimate By 2015

Seeking Alpha

Thu, 12/8/11 - 11:33 am

Savient Pharmaceuticals: The Potential Role Of Krystexxa The Treatment Of Gout

Seeking Alpha

Sat, 12/3/11 - 11:06 am

Savient Pharmaceuticals: Sluggish Launch Of Krystexxa Presents Buying Opportunity

Seeking Alpha

Wed, 11/30/11 - 05:29 pm

Savient falls after analyst downgrades stock, expecting lower sales of its gout drug Krystexxa

Yahoo/AP

Fri, 11/11/11 - 09:50 am

Savient Pharmaceuticals Announces New Data Surrounding KRYSTEXXA® and the Impact of Refractory Chronic Gout at the American College of Rheumatology Meeting

Yahoo/PR NewsWire

Sat, 11/5/11 - 02:49 pm

New Medicare code could boost Krystexxa sales

Fierce Pharma

Fri, 11/4/11 - 12:19 pm

Gout drug developer Ardea reports bigger 3Q loss

Yahoo/AP

Fri, 11/4/11 - 12:17 pm

BioCryst says gout drug worked in mid-stage trial

Yahoo/AP

Wed, 10/5/11 - 10:54 am

Ardea Agrees with FDA on Gout Candidate

Yahoo/Zacks

Sat, 09/10/11 - 09:58 am

Ardea agrees with FDA on gout drug studies

Yahoo/AP

Thu, 09/8/11 - 11:16 am

FDA asks Novartis for more data on gout drug

Reuters

Mon, 08/29/11 - 01:11 pm

FDA votes against Novartis gout drug: WSJ

Marketwatch

Wed, 06/22/11 - 09:03 am

advisory panels

US FDA staff-Novartis gout drug data 'complicated'

Reuters

Fri, 06/17/11 - 12:22 pm

Ardea shares climb after release of study results

Yahoo/AP

Fri, 05/27/11 - 08:54 am

A.M. Vitals: Novartis Says Experimental Gout Drug is Effective

Wed, 05/25/11 - 10:04 pm

Ardea Biosciences Evenly Poised

Yahoo/Zacks.com

Wed, 05/25/11 - 09:50 am

Novartis Says Experimental Gout Drug is Effective

WSJ Online

Wed, 05/25/11 - 09:21 am

Pages